RESIDUES WITHIN A CONSERVED AMINO-ACID MOTIF OF DOMAIN-1 AND DOMAIN-4 OF VCAM-1 ARE REQUIRED FOR BINDING TO VLA-4

被引:163
|
作者
VONDERHEIDE, RH
TEDDER, TF
SPRINGER, TA
STAUNTON, DE
机构
[1] HARVARD UNIV, SCH MED, DANA FARBER CANC INST, CTR BLOOD RES, BOSTON, MA 02115 USA
[2] HARVARD UNIV, SCH MED, DANA FARBER CANC INST, DIV TUMOR IMMUNOL, BOSTON, MA 02115 USA
[3] HARVARD UNIV, SCH MED, DEPT PATHOL, BOSTON, MA 02115 USA
来源
JOURNAL OF CELL BIOLOGY | 1994年 / 125卷 / 01期
关键词
D O I
10.1083/jcb.125.1.215
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Vascular cell adhesion molecule 1 (VCAM-1), a member of the Ig superfamily originally identified on activated endothelium, binds to the integrin very late antigen-4 (VLA-4), also known as alpha4beta1 or CD49d/CD29, to support cell-cell adhesion. Studies based on cell adhesion to two alternatively spliced forms of VCAM-1 or to chimeric molecules generated from them and intercellular adhesion molecule-1 (ICAM-1) have demonstrated two VLA-4 binding sites on the predominate form of VCAM-1. Here, we studied VLA-4-dependent adhesion of the lymphoid tumor cell line Ramos to cells expressing wild type and mutant forms of VCAM-1. Results based on domain deletion mutants demonstrated the existence and independence of two VLA-4-binding sites located in the first and fourth domains of VCAM-1. Results based on amino acid substitution mutants demonstrated that residues within a linear sequence of six amino acids found in both domain 1 and 4 were required for VLA-4 binding to either domain. Five of these amino acids represent a conserved motif also found in ICAM domains. We propose that integrin binding to these Ig-like domains depends on residues within this conserved motif. Specificity of integrin binding to Ig-like domains may be regulated by a set of nonconserved residues distinct from the conserved motif.
引用
收藏
页码:215 / 222
页数:8
相关论文
共 50 条
  • [31] Essential role of VLA-4/VCAM-1 pathway in the establishment of Trypanosoma cruzi-elicited meningoencephalitis
    Lannes-Vieira, J
    Roffê, E
    Silva, A
    Marino, AP
    JOURNAL OF NEUROIMMUNOLOGY, 2004, 154 (1-2) : 71 - 71
  • [32] Quantitative Structure Activity Relationship Studies of Piperazinyl Phenylalanine Derivatives as VLA-4/VCAM-1 Inhibitors
    Bhargava, Dinesh
    Karthikeyan, C.
    Moorthy, N. S. H. N.
    Trivedi, Piyush
    MEDICINAL CHEMISTRY, 2009, 5 (05) : 446 - 454
  • [33] Suppression of experimental autoimmune encephalomyelitis with a TNF binding protein (TNFbp) correlates with down-regulation of VCAM-1/VLA-4
    Selmaj, K
    Walczak, A
    Mycko, M
    Berkowicz, T
    Kohno, T
    Raine, CS
    EUROPEAN JOURNAL OF IMMUNOLOGY, 1998, 28 (06) : 2035 - 2044
  • [34] THE VCAM-1/VLA-4 PATHWAY IS INVOLVED IN CHRONIC LESION EXPRESSION IN MULTIPLE-SCLEROSIS (MS)
    CANNELLA, B
    RAINE, CS
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 1993, 52 (03): : 311 - 311
  • [35] Increased Levels of VCAM-1 in Sera and VLA-4 Expression on Neutrophils in Dermatomyositis with Interstitial Lung Disease
    Lin, Meiyi
    Yang, Chunshu
    Liu, Xudong
    Zhao, Shan
    Tian, Bailing
    Hou, Xiaoyu
    Xu, Jingyi
    Yang, Pingting
    IMMUNOLOGICAL INVESTIGATIONS, 2022, 51 (04) : 980 - 992
  • [36] Effect of eight VLA-4 antagonists on human eosinophil adhesion to immobilized human VCAM-1 in vitro
    Bochner, BS
    Hudson, SA
    Wasserman, MA
    Stilz, HU
    Wehner, V
    Wolos, JA
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2000, 105 (01) : S258 - S259
  • [37] CRYSTALLIZATION AND PRELIMINARY-X-RAY DIFFRACTION CHARACTERIZATION OF BOTH A NATIVE AND SELENOMETHIONYL VLA-4 BINDING FRAGMENT OF VCAM-1
    BOTTOMLEY, MJ
    ROBINSON, RC
    DRISCOLL, PC
    HARLOS, K
    STUART, DI
    APLIN, RT
    CLEMENTS, JM
    JONES, EY
    DUDGEON, TJ
    JOURNAL OF MOLECULAR BIOLOGY, 1994, 244 (04) : 464 - 468
  • [38] Interaction of mesenchymal stem cells with the endothelial barrier: Role of endothelial phenotype and VLA-4/VCAM-1
    Steingen, C
    Schmidt, A
    Brixius, K
    Bloch, W
    EUROPEAN JOURNAL OF CELL BIOLOGY, 2006, 85 : 103 - 103
  • [39] Inhibition of LFA-1/ICAM-1 and VLA-4/VCAM-1 as a therapeutic approach to inflammation and autoimmune diseases
    Yusuf-Makagiansar, H
    Anderson, ME
    Yakovleva, TV
    Murray, JS
    Siahaan, TJ
    MEDICINAL RESEARCH REVIEWS, 2002, 22 (02) : 146 - 167
  • [40] Chemerin Contributes to Inflammation by Promoting Macrophage Adhesion to VCAM-1 and Fibronectin through Clustering of VLA-4 and VLA-5
    Hart, Rosie
    Greaves, David R.
    JOURNAL OF IMMUNOLOGY, 2010, 185 (06): : 3728 - 3739